Back to search

Iceland· IS-EU/1/18/1339/001-002

Bevespi Aerosphere

A formoterol und glycopyrronium bromid product containing formoterolum inn fúmarat,glycopyrronii bromidum inn, registered in Iceland by AstraZeneca AB. The same ATC class is registered in 9 of our 19 countries.

ATC R03AL07

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedBevespi AerosphereATCR03AL07REGISTER NO.IS-EU/1/18/1339/001-0…PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Formoterol und glycopyrronium bromid is registered in 9 of 19 countries.

Countries holding a registration under ATC R03AL07 (formoterol und glycopyrronium bromid), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 6 of them publish a price we can compare per daily dose

Formoterol und glycopyrronium bromid · ATC R03AL07

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Formoterolum INN fúmarat,Glycopyrronii bromidum INN
Manufacturer
AstraZeneca AB
Country
Iceland (IS)
ATC code
R03AL07
ATC class
Formoterol und Glycopyrronium bromid
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 1

1 priced
  • ean
    991572
    120 skammtar x1 pakki
    ISK 20730

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c4d3e484-34b5-4681-be67-33a76108b854
GET /v1/drugs/c4d3e484-34b5-4681-be67-33a76108b854?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Innúðalyf, dreifa",
  "source": "lyfjastofnun",
  "atc_raw": "R03AL07",
  "marketed": false,
  "strength": "7,5 míkróg/5 míkróg/úðaskammt",
  "ma_number": "EU/1/18/1339/001-002",
  "substance": "Formoterolum INN fúmarat,Glycopyrronii bromidum INN",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "43452"
}

See everything about formoterol und glycopyrronium bromid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.